Variability of in situ proteomic profiling and implications for study design in colorectal tumors

International Journal of Oncology

Volumn 31, Issue 1, 2007, Pages 103-111

  Li, Jia Qing ^a   Xu, Baogang J ^b,c   Shakhtour, Bashar ^a   Deane, Natasha ^a   Merchant, Nipun ^a,c   Heslin, Martin J ^d   Washington, Kay ^a,c   Coffey, Robert J ^a,b,c   Beauchamp, R Daniel ^a,b,c   Shyr, Yu ^a,c   Billheimer, Dean ^a,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d Kentucky   (United States)

Author keywords

Colorectal tumor; In situ; Proteomic profiling; Variability

Indexed keywords

TUMOR PROTEIN;

ANIMAL; ARTICLE; CARCINOMA; COLORECTAL TUMOR; HUMAN; MASS SPECTROMETRY; METABOLISM; MOUSE; PATHOLOGY; PROTEIN MICROARRAY; PROTEOMICS;

ANIMALS; CARCINOMA; COLORECTAL NEOPLASMS; HUMANS; MICE; NEOPLASM PROTEINS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34548593236     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.31.1.103     Document Type: Article

References (27)

1. Blackhall FH, Pintilie M, Wigle DA, Jurisica I, Liu N, Radulovich N, Johnston MR, Keshavjee S and Tsao MS: Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection. Neoplasia 6: 761-767, 2004.
2. Francis P, Fernebro J, Eden P, Laurell A, Rydholm A, Domanski HA, Breslin T, Hegardt C, Borg A and Nilbert M: Intratumor versus intertumor heterogeneity in gene expression profiles of soft-tissue sarcomas. Genes Chromosomes Cancer 43: 302-308, 2005. (Pubitemid 40726875)
3. O'Sullivan M, Budhraja V, Sadovsky Y and Pfeifer JD: Tumor heterogeneity affects the precision of microarray analysis. Diagn Mol Pathol 14: 65-71, 2005.
4. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, Mollenkopf HJ, Kaufmann SH and Ziegler A: Deconfounding microarray analysis-independent measurements of cell type proportions used in a regression model to resolve tissue heterogeneity bias. Methods Inf Med 45: 557-563, 2006.
5. Chaurand P, Sanders ME, Jensen RA and Caprioli RM: Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. Am J Pathol 165: 1057-1068, 2004.
6. Caldwell RL and Caprioli RM: Tissue profiling by mass spectrometry: a review of methodology and applications. Mol Cell Proteomics 4: 394-401, 2005.
7. Reyzer ML and Caprioli RM: MALDI mass spectrometry for direct tissue analysis: a new tool for biomarker discovery. J Proteome Res 4: 1138-1142, 2005.
8. Chaurand P, Da Gue BB, Ma S, Kasper S and Caprioli RM: Strain-based sequence variations and structure analysis of murine prostate specific spermine binding protein using mass spectrometry. Biochemistry 40: 9725-9733, 2001.
9. Reyzer ML, Caldwell RL, Dugger TC, Forbes JT, Ritter CA, Guix M, Arteaga CL and Caprioli RM: Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res 64: 9093-9100, 2004.
10. Xie L, Xu BJ, Gorska AE, Shyr Y, Schwartz SA, Cheng N, Levy S, Bierie B, Caprioli RM and Moses HL: Genomic and proteomic analysis of mammary tumors arising in transgenic mice. J Proteome Res 4: 2088-2098, 2005.
11. Schwartz SA, Weil RJ, Johnson MD, Toms SA and Caprioli RM: Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression. Clin Cancer Res 10: 981-987, 2004.
12. Rahman SM, Shyr Y, Yildiz PB, Gonzalez AL, Li H, Zhang X, Chaurand P, Yanagisawa K, Slovis BS, Miller RF, Ninan M, Miller YE, Franklin WA, Caprioli RM, Carbone DP and Massion PP: Proteomic patterns of preinvasive bronchial lesions. Am J Respir Crit Care Med 172: 1556-1562, 2005.
13. Schwartz SA, Weil RJ, Thompson RC, Shyr Y, Moore JH, Toms SA, Johnson MD and Caprioli RM: Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res 65: 7674-7681, 2005.
14. Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, Moore JH, Caprioli RM and Carbone DP: Proteomic patterns of tumour subsets in non-small cell lung cancer. Lancet 362: 433-439, 2003.
15. Xu BJ, Caprioli RM, Sanders ME and Jensen RA: Direct analysis of laser capture microdissected cells by MALDI mass spectrometry. J Am Soc Mass Spectrom 13: 1292-1297, 2002.
16. Cornett DS, Mobley JA, Dias EC, Andersson M, Arteaga CL, Sanders ME and Caprioli RM: A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. Mol Cell Proteomics 5: 1975-1983, 2006.
17. Aerni HR, Cornett DS and Caprioli RM: Automated acoustic matrix deposition for MALDI sample preparation. Anal Chem 78: 827-834, 2006.
18. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG and Morrow M: AJCC Cancer Staging Manual. 6th edition. Springer, New York, 2002.
19. Xu BJ, Shyr Y, Liang X, Ma LJ, Donnert EM, Roberts JD, Zhang X, Kon V, Brown NJ, Caprioli RM and Fogo AB: Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol 16: 2967-2975, 2005.
20. Neter J, Kutner MH, Nachtsheim CJ and Wasserman W: Applied Linear Statistical Models. 4th edition. Irwin Publishing, Chicago, IL, 1996.
21. Tukey JW: Exploratory Data Analysis. Addison-Wesley, Reading, 1977.
22. R-Development-Core-Team: R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, 2006.
23. Masumori N, Thomas TZ, Chaurand P, Case T, Paul M, Kasper S, Caprioli RM, Tsukamoto T, Shappell SB and Matusik RJ: A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Cancer Res 61: 2239-2249, 2001.
24. Pierson J, Norris JL, Aerni HR, Svenningsson P, Caprioli RM and Andren PE: Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. J Proteome Res 3: 289-295, 2004.
25. Roesch-Ely M, Nees M, Karsai S, Ruess A, Bogumil R, Warnken U, Schnolzer M, Dietz A, Plinkert PK, Hofele C and Bosch FX: Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene 26: 54-64, 2007.
26. Fletcher CDM: Diagnostic Histopathology of Tumors. Vol. 1, 2nd edition. Harcourt Publishers Ltd., London, pp171-930, 2000.
27. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.